BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2983850)

  • 1. delta-Opioid modulation of striatal dopaminergic activity in mice.
    Dua AK; Pinsky C
    Can J Neurol Sci; 1985 Feb; 12(1):60-4. PubMed ID: 2983850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticonvulsant effects of DADLE are primarily mediated by activation of delta opioid receptors: interactions between delta and mu receptor antagonists.
    Tortella FC; Robles L; Holaday JW
    Life Sci; 1985 Aug; 37(6):497-503. PubMed ID: 2991684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evidence for the selectivity of ICI 154129 for the delta-opioid receptor.
    Priestley T; Turnbull MJ; Wei E
    Neuropharmacology; 1985 Feb; 24(2):107-10. PubMed ID: 2986029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):278-84. PubMed ID: 3035383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
    Eur J Pharmacol; 1985 Dec; 118(3):363-6. PubMed ID: 2417870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu- and delta-opioid modulation of electrically-induced epileptic seizures in mice.
    Pinsky C; Bose R; Frederickson RC
    NIDA Res Monogr; 1986; 75():543-6. PubMed ID: 2829000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
    Arenas E; Alberch J; Marsal J
    Neuroscience; 1991; 42(3):707-14. PubMed ID: 1683474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M; La Regina A; Petrillo P; Tavani A
    NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors.
    Morelli M; Fenu S; Di Chiara G
    Brain Res; 1989 May; 487(1):120-30. PubMed ID: 2546645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid antinociceptive effects of delta-receptor antagonists.
    Leander JD; Gesellchen PD; Mendelsohn LG
    Pharmacol Biochem Behav; 1988 Feb; 29(2):351-5. PubMed ID: 2834753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICI 174,864, a selective delta opioid antagonist, reverses the learning impairment produced by [leu]enkephalin.
    Schulteis G; Martinez JL
    Psychopharmacology (Berl); 1990; 100(1):102-9. PubMed ID: 2153306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the effects of mu- and delta-opioid receptor antagonists upon plasma corticosterone levels in stressed mice.
    Kitchen I; Rowan KM
    Eur J Pharmacol; 1984 May; 101(1-2):153-6. PubMed ID: 6086360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
    Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L; Wire W
    Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition via opioid mu- and delta-receptors of vagal transmission in rabbit isolated heart.
    Weitzell R; Illes P; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):186-90. PubMed ID: 6098836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the delta-opiate antagonist ICI 154129.
    Volterra A; Brunello N; Cagiano R; Cuomo V; Racagni G
    J Pharm Pharmacol; 1984 Dec; 36(12):849-51. PubMed ID: 6151983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia.
    Chaillet P; Coulaud A; Zajac JM; Fournie-Zaluski MC; Costentin J; Roques BP
    Eur J Pharmacol; 1984 May; 101(1-2):83-90. PubMed ID: 6086366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mu- and delta-opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion.
    Rogers H; Henderson G
    Br J Pharmacol; 1990 Nov; 101(3):505-12. PubMed ID: 1981687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.